SCHEMBL19920167

SCHEMBL19920167

COc1ccccc1-c1cccc(CC=O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 6/20 0.64
DRD2 P14416 1/20 0.52
DRD4 P21917 1/20 0.52
DRD3 P35462 1/20 0.52
PTPN5 P54829 1/20 0.51
FFAR1 O14842 4/20 0.51
CASR P41180 1/20 0.50
PTPRC P08575 1/20 0.49
PTPN1 P18031 1/20 0.49
ERN1 O75460 2/20 0.48
FYN P06241 1/20 0.43
CHEK1 O14757 1/20 0.43
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2E1 P05181 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3786457 0.82 HTR7 (0.45) HTR7DRD2DRD4DRD3FFAR1
SCHEMBL12806502 0.82 HTR7 (0.69) HTR7DRD2DRD4DRD3PTPN5
SCHEMBL19043338 0.82 SLC13A5 (0.49) HTR7DRD2DRD4DRD3PTPRC
SCHEMBL7504815 0.81 HTR7 (0.68) HTR7DRD2DRD4DRD3PTPN5
SCHEMBL5992125 0.81 HTR7 (0.68) HTR7DRD2DRD4DRD3PTPN5
SCHEMBL13434073 0.81 HTR7 (0.68) HTR7DRD2DRD4DRD3PTPN5
SCHEMBL2934073 0.81 HTR7 (0.72) HTR7DRD2DRD4DRD3PTPN5
SCHEMBL4038548 0.81 FFAR1 (0.53) FFAR1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL3794909 0.80 PDE4D (0.48) HTR7PTPN5FFAR1CASRERN1
SCHEMBL12881923 0.79 HTR7 (0.71) HTR7DRD2DRD4DRD3PTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2782570-B1 HETEROCYCLIC INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES INC (US) 2019-09-18 EP disclosed
WO-2018039442-A1 TREATMENT OF CANCER WITH INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES, INC. (US) 2018-03-01 WO disclosed